Lead Generation Approaches Delivering Inhaled p2-Adrenoreceptor Agonist Drug Candidates

Lead Generation Approaches Delivering Inhaled P2 Adrenoreceptor Agonist Drug Candidates 

Lead Generation Methods, Strate es, and Case Studies, First Edition. Edited by Jorg Holenz. 

In addition to the aforementioned concepts of increasing inhalation duration of action, scientists from AstraZeneca have recently published key concepts toward the optimization of duration of action through optimization of the drug metabolism and pharmacokinetics (DMPK) of the inhaled therapy [14], 

Guinea Pig bronchoprotection duration of action and safety measurements 

Lead Generation Exercises to Discover P2AR Agonist Clinical Candidates 

---